Patient Preferences and Treatment Satisfaction in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Approved C5 Inhibitors in the Phase III Randomized COMMODORE 1 and COMMODORE 2 Trials

被引：3

作者：

Kulasekararaj, Austin ^{[1
,2
]}

Gonzalez Fernandez, Fernando Ataulfo ^{[3
]}

Scheinberg, Phillip ^{[4
]}

Straetmans, Nicole ^{[5
]}

Ueda, Yasutaka ^{[6
]}

Gentile, Brittany ^{[7
]}

Stefani, Jennifer ^{[8
]}

Uguen, Marianne ^{[8
]}

Roeth, Alexander ^{[9
,10
]}

机构：

[1] Kings Coll Hosp London, Dept Haematol Med, London, England

[2] Natl Inst Hlth & Care Res & Wellcome Kings Res Fa, London, England

[3] Hosp Clin San Carlos, Hematol Serv, Madrid, Spain

[4] Hosp Beneficencia Portuguesa Sao Paulo, Sao Paulo, Brazil

[5] St Luc Univ Hosp, Dpt Haematol, Brussels, Belgium

[6] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Fac Med, Suita, Osaka, Japan

[7] Genentech Inc, San Francisco, CA USA

[8] F Hoffmann Roche Ltd, Basel, Switzerland

[9] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany

[10] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, West German Canc Ctr, Essen, Germany

来源：

关键词：

D O I：

10.1182/blood-2023-178610

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5